Photocure ASA

Photocure ASA: Exercise of employee share options

Oslo, Norway, 31 August 2021: Reference is made to the stock exchange release by

Photocure ASA ("Photocure" or the "Company") published on 30 August 2021

regarding exercise of share options.

The price for option shares sold by the primary insider, Geoffrey Coy, VP &

General Manager US Operations, has been determined at a price of NOK 113.6148

per share.

The primary insider having exercised options has used the net proceeds from the

sale of option shares to purchase 7,126 shares in Photocure at a price per share

of NOK 113.6148 as follows:

The shares are purchased at the stated price from Photocure's holding of own

shares. Following the transaction Photocure will hold 21,010 own shares.

Primary insider notification pursuant to the market abuse regulation article 19

is attached.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com, www.hexvix.com or www.cysview.com

All trademarks mentioned in this release are protected by law and are registered

trademarks of Photocure ASA.

This information is subject to the disclosure requirements pursuant to the

market abuse regulation article 19 and 5-12 of the Norwegian Securities Trading

Act.

AI Terminal